These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27575988)

  • 1. RAGs and BUGS: An alliance for autoimmunity.
    Rigoni R; Grassi F; Villa A; Cassani B
    Gut Microbes; 2016 Nov; 7(6):503-511. PubMed ID: 27575988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects.
    Rigoni R; Fontana E; Guglielmetti S; Fosso B; D'Erchia AM; Maina V; Taverniti V; Castiello MC; Mantero S; Pacchiana G; Musio S; Pedotti R; Selmi C; Mora JR; Pesole G; Vezzoni P; Poliani PL; Grassi F; Villa A; Cassani B
    J Exp Med; 2016 Mar; 213(3):355-75. PubMed ID: 26926994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
    Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
    Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omenn syndrome does not live by V(D)J recombination alone.
    Marrella V; Maina V; Villa A
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.
    Delmonte OM; Villa A; Notarangelo LD
    Blood; 2020 Feb; 135(9):610-619. PubMed ID: 31942628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
    Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
    J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
    Walter JE; Rosen LB; Csomos K; Rosenberg JM; Mathew D; Keszei M; Ujhazi B; Chen K; Lee YN; Tirosh I; Dobbs K; Al-Herz W; Cowan MJ; Puck J; Bleesing JJ; Grimley MS; Malech H; De Ravin SS; Gennery AR; Abraham RS; Joshi AY; Boyce TG; Butte MJ; Nadeau KC; Balboni I; Sullivan KE; Akhter J; Adeli M; El-Feky RA; El-Ghoneimy DH; Dbaibo G; Wakim R; Azzari C; Palma P; Cancrini C; Capuder K; Condino-Neto A; Costa-Carvalho BT; Oliveira JB; Roifman C; Buchbinder D; Kumanovics A; Franco JL; Niehues T; Schuetz C; Kuijpers T; Yee C; Chou J; Masaad MJ; Geha R; Uzel G; Gelman R; Holland SM; Recher M; Utz PJ; Browne SK; Notarangelo LD
    J Clin Invest; 2015 Nov; 125(11):4135-48. PubMed ID: 26457731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HyperIgE in hypomorphic recombination-activating gene defects.
    Castiello MC; Brandas C; Capo V; Villa A
    Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration.
    Maina V; Marrella V; Mantero S; Cassani B; Fontana E; Anselmo A; Del Prete A; Sozzani S; Vezzoni P; Poliani PL; Villa A
    J Leukoc Biol; 2013 Dec; 94(6):1221-30. PubMed ID: 24052573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models.
    Milner JD; Fasth A; Etzioni A
    J Clin Immunol; 2008 May; 28 Suppl 1():S29-33. PubMed ID: 18193342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutations.
    Matangkasombut P; Pichavant M; Saez DE; Giliani S; Mazzolari E; Finocchi A; Villa A; Sobacchi C; Cortes P; Umetsu DT; Notarangelo LD
    Blood; 2008 Jan; 111(1):271-4. PubMed ID: 17890453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic and biochemical basis of Omenn syndrome.
    Santagata S; Villa A; Sobacchi C; Cortes P; Vezzoni P
    Immunol Rev; 2000 Dec; 178():64-74. PubMed ID: 11213808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly variable clinical phenotypes of hypomorphic RAG1 mutations.
    Avila EM; Uzel G; Hsu A; Milner JD; Turner ML; Pittaluga S; Freeman AF; Holland SM
    Pediatrics; 2010 Nov; 126(5):e1248-52. PubMed ID: 20956421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative CD4 lymphopenia and a skewed memory phenotype are the main immunologic abnormalities in a child with Omenn syndrome due to homozygous RAG1-C2633T hypomorphic mutation.
    McCusker C; Hotte S; Le Deist F; Hirschfeld AF; Mitchell D; Nguyen VH; Gagnon R; Mazer B; Turvey SE; Jabado N
    Clin Immunol; 2009 Jun; 131(3):447-55. PubMed ID: 19246248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.